Search research articles
Contact Us
Filters
Showing results (331-340 of 392) with videos related to
Page
of 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
Peter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Radiology
|
October 1, 1989
Oocyte retrieval in an in vitro fertilization-embryo transfer program: comparison of four methods
D A Wiseman, W B Short, H A Pattinson, et al.
Clinical Lymphoma & Myeloma
|
May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma
Dimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Cancer
|
March 24, 2007
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan
Thomas E Witzig, Arturo Molina, Leo I Gordon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2002
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody
Henry N Wagner, Gregory A Wiseman, Carol S Marcus, et al.
Nature Reviews. Gastroenterology & Hepatology
|
November 3, 2009
Liver transplantation after radioembolization in a patient with unresectable HCC
Laura E Moreno Luna, Paul Y Kwo, Lewis R Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2003
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials
Gregory A Wiseman, Ellen Kornmehl, Bryan Leigh, et al.
Journal of Veterinary Internal Medicine
|
October 27, 2006
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations
M L Wagner, S J Valberg, E G Ames, et al.
Clinical Lymphoma & Myeloma
|
November 21, 2007
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Gregory A Wiseman, Peter S Conti, Katie Vo, et al.
Leukemia & Lymphoma
|
March 15, 2017
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue
Anthony Q Pham, Stephen M Broski, Thomas M Habermann, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 392) with videos related to
Sort By:
Page
of 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
Peter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Radiology
|
October 1, 1989
Oocyte retrieval in an in vitro fertilization-embryo transfer program: comparison of four methods
D A Wiseman, W B Short, H A Pattinson, et al.
Clinical Lymphoma & Myeloma
|
May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma
Dimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Cancer
|
March 24, 2007
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan
Thomas E Witzig, Arturo Molina, Leo I Gordon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2002
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody
Henry N Wagner, Gregory A Wiseman, Carol S Marcus, et al.
Nature Reviews. Gastroenterology & Hepatology
|
November 3, 2009
Liver transplantation after radioembolization in a patient with unresectable HCC
Laura E Moreno Luna, Paul Y Kwo, Lewis R Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2003
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials
Gregory A Wiseman, Ellen Kornmehl, Bryan Leigh, et al.
Journal of Veterinary Internal Medicine
|
October 27, 2006
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations
M L Wagner, S J Valberg, E G Ames, et al.
Clinical Lymphoma & Myeloma
|
November 21, 2007
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Gregory A Wiseman, Peter S Conti, Katie Vo, et al.
Leukemia & Lymphoma
|
March 15, 2017
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue
Anthony Q Pham, Stephen M Broski, Thomas M Habermann, et al.
Page
of 40